NEW YORK, NY — As the sun sets on October 13, 2026, the global skyline will undergo...
Asep Darmawan
By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation (NBCF) In recent years, Glucagon-Like Peptide-1 (GLP-1)...
The campaign arrives at a critical juncture in oncology. While advancements in screening have improved survival rates...
In a significant move to address one of the most challenging frontiers in modern oncology, Expert Review...
Navigating the Post-Treatment Journey: Breast Cancer Canada’s Fall Webinar Series Empowers Survivors
Navigating the Post-Treatment Journey: Breast Cancer Canada’s Fall Webinar Series Empowers Survivors
For many breast cancer patients, the conclusion of active treatment—chemotherapy, radiation, or surgery—is often viewed as a...
The international public health landscape has been profoundly shaped by the partnership between the United States and...
AMMAN, JORDAN — The Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, has concluded...
For many patients, the end of active breast cancer treatment—the final infusion or the last radiation session—is...
TORONTO, ON – As the medical community continues to make strides in early detection and targeted therapies,...
NORMAN, OK – In a significant leap forward for cancer research, scientists at the University of Oklahoma...
